1-10 of 10
Kelvin KW Chan
Close
Sort by
Journal Articles

Assessing the Impact of Marginalization on Survival for Patients Undergoing Allogeneic Stem Cell Transplant in Ontario, Canada

Adam Suleman, Sho Podolsky, Ning Liu, Kelvin KW Chan, Sumedha Arya, Lisa Hicks, Matthew C. Cheung, Anca Prica
Journal: Blood
Blood (2023) 142 (Supplement 1): 5175.
https://doi.org/10.1182/blood-2023-185351
Published: 2023
Journal Articles

Assessing the Impact of Marginalization on Survival for Patients Undergoing Autologous Stem Cell Transplant in Ontario, Canada

Adam Suleman, Sho Podolsky, Ning Liu, Kelvin KW Chan, Sumedha Arya, Lisa Hicks, Matthew C. Cheung, Anca Prica
Journal: Blood
Blood (2023) 142 (Supplement 1): 2389.
https://doi.org/10.1182/blood-2023-173609
Published: 2023
Journal Articles

Outcomes of Transplant-Eligible and Transplant-Ineligible Patients with Mantle Cell Lymphoma in Ontario, Canada

Adam Suleman, Zharmaine Ante, Ning Liu, Michael Crump, Kelvin KW Chan, Matthew C. Cheung, Anca Prica
Journal: Blood
Blood (2023) 142 (Supplement 1): 1665.
https://doi.org/10.1182/blood-2023-177788
Published: 2023
Journal Articles

Comparison of the Efficacy in Clinical Trials Versus Effectiveness in the Real-World of Treatments for Multiple Myeloma: A Population-Based Cohort Study

Alissa Visram, Kelvin KW Chan, Hsien Seow, Gregory Pond, Ana Gayowsky, Arleigh McCurdy, Irwindeep Sandhu, Christopher P. Venner, Guido Lancman, Amaris Balitsky, Robert Bruins, Shaji Kunnathu Kumar, Rafael Fonseca, Hira Mian
Journal: Blood
Blood (2023) 142 (Supplement 1): 541.
https://doi.org/10.1182/blood-2023-189506
Published: 2023
Journal Articles

The Impact of Drug Interactions on Outcomes in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia in Routine Clinical Care: A Population-Based Cohort Study

Tuan Hoang, Matthew C. Cheung, Kelvin KW Chan, Cindy Lau, Ning Liu, Husam Abdel-Qadir, David Juurlink, Anca Prica, Alia Thawer, Abi Vijenthira, Lee Mozessohn
Journal: Blood
Blood (2022) 140 (Supplement 1): 2159–2160.
https://doi.org/10.1182/blood-2022-158768
Published: 2022
Journal Articles

Granulocyte-Colony Stimulating Factor (G-CSF) in Secondary Prophylaxis for Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Cost-Effectiveness Analysis

Matthew C Cheung, Anca Prica, MD, Joanna Graczyk, MD, Rena Buckstein, MD, Kelvin KW Chan, MD
Journal: Blood
Blood (2014) 124 (21): 737.
https://doi.org/10.1182/blood.V124.21.737.737
Published: 2014
Journal Articles

Adjusting For Drug Wastage In Economic Evaluations Of New Therapies For Hematologic Malignancies: A Systematic Review Of The Literature and Implications

Matthew C. Cheung, MD, Maureen E. Trudeau, Anca Prica, MD, Rena Buckstein, MD, Kelvin KW Chan, MD
Journal: Blood
Blood (2013) 122 (21): 2928.
https://doi.org/10.1182/blood.V122.21.2928.2928
Published: 2013
Journal Articles

Frontline Rituximab Monotherapy Induction Versus a Watch and Wait Approach For Asymptomatic Advanced Stage Follicular Lymphoma: A Cost-Effectiveness Analysis

Anca Prica, MD, Kelvin KW Chan, MD, Matthew C Cheung, MD
Journal: Blood
Blood (2013) 122 (21): 2941.
https://doi.org/10.1182/blood.V122.21.2941.2941
Published: 2013
Journal Articles

Combined Modality Therapy Versus Chemotherapy Alone As an Induction Regimen for Primary CNS Lymphoma: A Cost-Effectiveness Analysis

Anca Prica, MD, Kelvin KW Chan, MD, MSc, FRCPC, Matthew Cheung, MD, MS, FRCP
Journal: Blood
Blood (2012) 120 (21): 969.
https://doi.org/10.1182/blood.V120.21.969.969
Published: 2012
Journal Articles

Publication Patterns of Cancer Cost-Effectiveness Studies Presented at the American Society of Hematology: Timeliness of Publication, Quality and Possible Bias.

Lee Mozessohn, MD, Kelvin KW Chan, MD, MSc, FRCPC, Matthew C Cheung, MD, SM, FRCPC
Journal: Blood
Blood (2010) 116 (21): 3816.
https://doi.org/10.1182/blood.V116.21.3816.3816
Published: 2010